D.E. Shaw & Co’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-18,700
Closed -$3.98M 4398
2014
Q4
$3.98M Hold
18,700
0.01% 1739
2014
Q3
$3.33M Hold
18,700
﹤0.01% 1833
2014
Q2
$3.16M Sell
18,700
-30,000
-62% -$4.67M ﹤0.01% 1952
2014
Q1
$6.04M Buy
48,700
+37,000
+316% +$4.51M 0.01% 1431
2013
Q4
$1.3M Sell
11,700
-27,500
-70% -$2.63M ﹤0.01% 2937
2013
Q3
$3.55M Hold
39,200
0.01% 1908
2013
Q2
$3.3M Buy
+39,200
New +$4.07M 0.01% 1671

Other funds holding AGN

D.E. Shaw & Co's AGN Position: Q1 2015 in Review

D.E. Shaw & Co sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 1,757,200 shares — an estimated $374M sold.

D.E. Shaw & Co first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $374M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • D.E. Shaw & Co reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • D.E. Shaw & Co sold 1,757,200 Allergan Inc shares in Q1 2015, an estimated $374M.
  • D.E. Shaw & Co first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • D.E. Shaw & Co's Allergan Inc position peaked at $374M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.